Cheng’en Hu

1.1k total citations
15 papers, 870 citations indexed

About

Cheng’en Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cheng’en Hu has authored 15 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Cheng’en Hu's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Cheng’en Hu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Cheng’en Hu collaborates with scholars based in China. Cheng’en Hu's co-authors include Guangjian Huang, Jun Gan, Jing Zhao, Wenhong Zhang, Peizhun Du, Yongchao Liu, Yunyun Qin, Guangjian Huang, Lun–Xiu Qin and Zhongwen Zhou and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Cheng’en Hu

14 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng’en Hu China 10 616 551 176 140 58 15 870
Shouzhen Wu China 12 516 0.8× 416 0.8× 171 1.0× 107 0.8× 32 0.6× 27 740
Wenjie Liao China 7 732 1.2× 594 1.1× 90 0.5× 200 1.4× 78 1.3× 12 935
Irem Kaymak United States 10 327 0.5× 273 0.5× 212 1.2× 160 1.1× 41 0.7× 12 628
Hongxing Shen United States 13 400 0.6× 353 0.6× 121 0.7× 119 0.8× 49 0.8× 22 672
Long Shen China 13 411 0.7× 208 0.4× 236 1.3× 110 0.8× 33 0.6× 21 683
Enhua Wang China 16 651 1.1× 614 1.1× 92 0.5× 154 1.1× 41 0.7× 26 867
Yanxia Lu China 19 1.0k 1.7× 843 1.5× 110 0.6× 194 1.4× 46 0.8× 28 1.3k

Countries citing papers authored by Cheng’en Hu

Since Specialization
Citations

This map shows the geographic impact of Cheng’en Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng’en Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng’en Hu more than expected).

Fields of papers citing papers by Cheng’en Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng’en Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng’en Hu. The network helps show where Cheng’en Hu may publish in the future.

Co-authorship network of co-authors of Cheng’en Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng’en Hu. A scholar is included among the top collaborators of Cheng’en Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng’en Hu. Cheng’en Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Du, Peizhun, et al.. (2024). Role of exhaled hydrogen sulfide in the diagnosis of colorectal cancer. BMJ Open Gastroenterology. 11(1). e001229–e001229. 5 indexed citations
2.
Du, Peizhun, Pengcheng Liu, Rajan S. Patel, et al.. (2023). The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer. Frontiers in Oncology. 12. 1019909–1019909. 1 indexed citations
3.
Fu, Yan, Cheng’en Hu, Peizhun Du, & Guangjian Huang. (2021). E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes. Journal of Oncology. 2021. 1–11. 11 indexed citations
4.
Du, Peizhun, Cheng’en Hu, Yunyun Qin, et al.. (2019). LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer. Journal of Oncology. 2019. 1–10. 60 indexed citations
5.
Zhao, Jing, Peizhun Du, Peng Cui, et al.. (2018). LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene. 37(30). 4094–4109. 280 indexed citations
6.
Fu, Yan, Peizhun Du, Jing Zhao, et al.. (2018). Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches. Yonsei Medical Journal. 59(10). 1150–1150. 44 indexed citations
7.
Du, Peizhun, Jing Zhao, Jing Wang, et al.. (2017). Sine Oculis Homeobox Homolog 1 Regulates Mitochondrial Apoptosis Pathway Via Caspase-7 In Gastric Cancer Cells. Journal of Cancer. 8(4). 636–645. 21 indexed citations
8.
Hu, Cheng’en & Jun Gan. (2017). TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer. Molecular Medicine Reports. 15(3). 1057–1062. 35 indexed citations
9.
Liu, Yongchao, Jing Zhao, Wenhong Zhang, et al.. (2015). lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Scientific Reports. 5(1). 10159–10159. 184 indexed citations
10.
Hu, Cheng’en, Yongchao Liu, Huidong Zhang, & Guangjian Huang. (2014). JMJD2A predicts prognosis and regulates cell growth in human gastric cancer. Biochemical and Biophysical Research Communications. 449(1). 1–7. 40 indexed citations
11.
Liu, Yongchao, et al.. (2014). Comprehensive Analysis of Vascular Endothelial Growth Factor-C Related Factors in Stomach Cancer. Asian Pacific Journal of Cancer Prevention. 15(5). 1925–1929. 9 indexed citations
12.
Hu, Cheng’en, et al.. (2014). The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a. Biochemical and Biophysical Research Communications. 448(4). 437–442. 39 indexed citations
13.
Zhang, Chunfen, et al.. (2014). Whole mitochondrial genome sequence of a rat colorectal cancer MCA38 cell line. Mitochondrial DNA Part A. 27(3). 2034–2035.
14.
Hu, Cheng’en, et al.. (2010). Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scandinavian Journal of Gastroenterology. 46(2). 156–164. 132 indexed citations
15.
Wang, Shufen, et al.. (2007). Novel silica‐coated iron–carbon composite particles and their targeting effect as a drug carrier. Journal of Biomedical Materials Research Part A. 86A(3). 671–677. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026